Guanidinium rich peptide transporters and drug delivery.
The use of peptide or peptidomimetic transporters to enable or enhance the uptake of drugs or probe molecules into cells and tissues has received increasing research attention and clinical interest over the past 10 years. This review summarizes a class of transporters that have been studied and focuses on the variation and use of guanidinium based transporters to facilitate the uptake of various types of molecules into cells and tissues. Lead conjugates in this area are currently in clinical trials.
Wright
Lee R
LR
Department of Chemistry, Stanford University, Stanford, California 95304, USA.
Rothbard
Jonathan B
JB
Wender
Paul A
PA
D000818:Animals; D001692:Biological Transport; D002352:Carrier Proteins / Q000138:chemical synthesis / Q000737:chemistry* / Q000378:metabolism*; D004337:Drug Carriers; D019791:Guanidine / Q000031:analogs & derivatives* / Q000138:chemical synthesis* / Q000378:metabolism; D006801:Humans; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry* / Q000493:pharmacokinetics*; D034444:Peptoids / Q000138:chemical synthesis / Q000737:chemistry / Q000191:economics; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000378:metabolism*
D002352:Carrier Proteins; D004337:Drug Carriers; D010455:Peptides; D034444:Peptoids; D004364:Pharmaceutical Preparations; D019791:Guanidine